US5341871094 - Common Stock

**LNC** gets a fundamental rating of **3** out of 10. The analysis compared the fundamentals against 142 industry peers in the **Insurance** industry. Both the profitability and financial health of **LNC** have multiple concerns. **LNC** is cheap, but on the other hand it scores bad on growth. **LNC** also has an excellent dividend rating.

In multiple years **LNC** reported negative net income over the last 5 years.

The reported operating cash flow has been mixed in the past 5 years: **LNC** reported negative operating cash flow in multiple years.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 0.12% | ||

ROE | 12.63% | ||

ROIC | 0.21% |

ROA(3y)-0.14%

ROA(5y)0%

ROE(3y)-15.65%

ROE(5y)-8.05%

ROIC(3y)N/A

ROIC(5y)N/A

Looking at the **Profit Margin**, with a value of **2.25%**, **LNC** is doing worse than **67.38%** of the companies in the same industry.

The **Operating Margin** of **LNC** (**4.96%**) is worse than **65.25%** of its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 4.96% | ||

PM (TTM) | 2.25% | ||

GM | N/A |

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

The number of shares outstanding for **LNC** has been increased compared to 1 year ago.

Compared to 5 years ago, **LNC** has less shares outstanding

Compared to 1 year ago, **LNC** has an improved debt to assets ratio.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 1.85 | ||

Debt/FCF | 7.25 | ||

Altman-Z | N/A |

ROIC/WACCN/A

WACCN/A

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | N/A | ||

Quick Ratio | N/A |

The earnings per share for **LNC** have decreased strongly by **-30.70%** in the last year.

The Revenue for **LNC** has decreased by **-17.95%** in the past year. This is quite bad

Measured over the past years, **LNC** shows a decrease in **Revenue**. The Revenue has been decreasing by **-3.31%** on average per year.

EPS 1Y (TTM)-30.7%

EPS 3Y6.93%

EPS 5Y-9.25%

EPS growth Q2Q-83.45%

Revenue 1Y (TTM)-17.95%

Revenue growth 3Y-7.26%

Revenue growth 5Y-3.31%

Revenue growth Q2Q2.94%

The **Revenue** is expected to grow by **0.38%** on average over the next years.

EPS Next Y32.35%

EPS Next 2Y18.34%

EPS Next 3Y19.5%

EPS Next 5YN/A

Revenue Next Year-0.23%

Revenue Next 2Y0.27%

Revenue Next 3Y0.38%

Revenue Next 5YN/A

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

With a **Price/Earnings** ratio of **5.72**, the valuation of **LNC** can be described as very cheap.

78.72% of the companies in the same industry are more expensive than **LNC**, based on the **Price/Earnings** ratio.

A **Price/Forward Earnings** ratio of **3.92** indicates a rather cheap valuation of **LNC**.

Based on the **Price/Forward Earnings** ratio, **LNC** is valued cheaply inside the industry as 84.40% of the companies are valued more expensively.

Compared to an average S&P500 **Price/Forward Earnings** ratio of **21.38**, **LNC** is valued rather cheaply.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 5.72 | ||

Fwd PE | 3.92 |

Based on the **Price/Free Cash Flow** ratio, **LNC** is valued a bit cheaper than the industry average as 68.09% of the companies are valued more expensively.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 5.64 | ||

EV/EBITDA | N/A |

The low **PEG Ratio(NY)**, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

A more expensive valuation may be justified as **LNC**'s earnings are expected to grow with **19.50%** in the coming years.

PEG (NY)0.18

PEG (5Y)N/A

EPS Next 2Y18.34%

EPS Next 3Y19.5%

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 6.44% |

On average, the dividend of **LNC** grows each year by **8.71%**, which is quite nice.

Dividend Growth(5Y)8.71%

Div Incr Years12

Div Non Decr Years13

DP93.07%

EPS Next 2Y18.34%

EPS Next 3Y19.5%

**LINCOLN NATIONAL CORP**

NYSE:LNC (2/22/2024, 12:31:06 PM)

**27.09**

**+0.11 (+0.41%) **

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupInsurance

GICS IndustryInsurance

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap4.60B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 6.44% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 5.72 | ||

Fwd PE | 3.92 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)0.18

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 0.12% | ||

ROE | 12.63% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 4.96% | ||

PM (TTM) | 2.25% | ||

GM | N/A | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.05

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 1.85 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | N/A | ||

Quick Ratio | N/A | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)-30.7%

EPS 3Y6.93%

EPS 5Y

EPS growth Q2Q

EPS Next Y32.35%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-17.95%

Revenue growth 3Y-7.26%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y